Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?

ABSTRACT:

SUBMITTER: Shing K 

PROVIDER: S-EPMC7812207 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature